CClinicalTrials.gg
CompletedNCT03060317Updated Jul 19, 2017

Validation of the Russian Version of Coma Recovery Scale-Revised (CRS-R)

An observational study in Consciousness Disorders, sponsored by Research Center of Neurology, Russia. Completed at 1 site in Russian Federation. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-07-19.

Sponsored by Research Center of Neurology, Russia · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
60
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to validate Russian version of Coma Recovery Scale - Revised and to assess its psychometric properties.

Read the detailed description

There is a need of validated scale for correct assessment for patients with disorders of consciousness (DOC) in Russia. One of the most detailed scales that provides robust results in these patients is the Coma Recovery Scale - Revised (CRS-r). The validated Russian version of CRS-r will be very helpful in clinical work and scientific research for making correct assessment of patients status and its changes over time in Russia and Russian-speaking countries.

The purpose of this study is to validate Russian version of CRS-R and to assess its psychometric properties.

The first step of the study was to perform translation of CRS-r from English into Russian according to the validation protocol:

  1. Double direct translation by independent translators;
  2. Combination of two Russian translations;
  3. Reverse translation by native English speaker.

Final Russian version and back-translated version of the Scale were approved by the original author, Dr. J. Giacino. He approved the original validation study protocol as well.

To validate Russian version of CRS-r and to assess its psychometric properties the investigators will perform an observational study on 60 adults with disorders of consciousness of different etiology on different period of recovery after coma. It is planned to include patients with various states of consciousness (e.g., vegetative state, minimally conscious state "minus" and minimally conscious state "plus") in balanced proportions.

Every patient will be examined by two independent researchers on the same day. The patients will be examined twice with a week interval between examinations for evaluation of sensitivity of CRS-r. Test-retest reliability will be applied to investigate interrater reliability. This method will be applied as well to assess the consistency of patients' scores over time. The internal consistency of the test will be investigated by inter-rater method. For this item two researchers will conduct patient assessment with CRS-R on the same day with a small period of time between the examinations. Content validity of the test will be used for assessment of validity of CRS-R. It will be performed with expert evaluation of the content of CRS-R by the investigators. Сriterion validity will be examined by assessing the correlations of CRS-R with the scales of other questionnaires with proven high psychometric properties for consciousness disorders: the Glasgow Coma Scale and Full Outline of UnResponsiveness (FOUR) score.

02

Conditions studied

  • Consciousness Disorders

Keywords

  • Disorders of consciousness
  • validation studies
  • coma
  • vegetative state
03

In context

Consciousness Disorders

236 studies on the registry are indexed under Consciousness Disorders; 102 are open to participants now.

This study's enrollment of 60 is below the median of 79 across 86 observational studies indexed under Consciousness Disorders.

Browse Consciousness Disorders studies →

Lead sponsor

Research Center of Neurology, Russia is the lead sponsor of 3 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The group of patients will be selected from residents of Research Center of Neurology, Moscow, Russia and patients of Moscow municipal hospitals.

Inclusion criteria

  • Adults recovering after coma in any period (persistent, permanent);
  • Vegetative state or minimal conscious state;
  • Locked-in syndrome.

Exclusion criteria

Exclusion Criteria:

  • Coma, brain death.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
60 participants (actual)
Patient registry
No

Groups and cohorts

  • Validation group DOC

    Examination with neurological scales.

    Behavioral: Examination with neurological scales.

Interventions

  • BehavioralExamination with neurological scales.

    Coma Recovery Scale, Glasgo Coma Scale, FOUR scale

06

What researchers measure

Primary outcomes

  1. Coma Recovery Scale-Revised

    Time frame: 1 week

07

Study locations

1 site
  • Research Center of Neurology
    Moscow, 125367, Russian Federation
08

References and documents

Publications

  • Giacino JT, Kalmar K, Whyte J. The JFK Coma Recovery Scale-Revised: measurement characteristics and diagnostic utility. Arch Phys Med Rehabil. 2004 Dec;85(12):2020-9. doi: 10.1016/j.apmr.2004.02.033. PubMed 15605342 ↗

Individual participant data

Plan to share: Yes — The investigators examine the patients with 3 scales. These original protocols could be observed by the participants after a request.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 19, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03060317
Lead sponsor
Research Center of Neurology, Russia
Responsible party
Sponsor
First posted
Feb 23, 2017
Start date
Nov 1, 2016
Primary completion
Jul 12, 2017
Completion
Jul 12, 2017
Last update
Jul 19, 2017

Study contacts

Michael A Piradov, PhD
study director · Research Center of Neurology, Moscow, Russia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion